…Data Sheet” https://www.gusmerenterprises.com/wp-content/uploads/2015/12/Talc-SDS.pdf 12) “Johnson & Johnson to End Talc-Based Baby Powder Sales in North America” https://www.nytimes.com/2020/05/19/business/johnson-baby-powder-sales-stopped.html 13) “Johnson & Johnson Ends North American Sales of Talc-Based Baby Powder” https://www.cancerhealth.com/article/johnson-johnson-ends-north-american-sales-talcbased-baby-powder…
…https://www.verywellhealth.com/black-box-warnings-1124107#what-does-one-look-like 10) “Physicians May Overlook Black Box Warnings” https://psychnews.psychiatryonline.org/doi/pdf/10.1176/pn.41.6.0013 11) “Consumers Tune Out FDA Warnings” https://money.cnn.com/2008/02/22/news/companies/fdawarning_fatigue/index.htm 12) “The consent risks with ‘black box’ warning medication” https://www.hrmronline.com/article/the-consent-risks-with-black-box-warning-medication 13) “What is a…
…Irbesartan” https://www.fda.gov/drugs/drug-safety-and-availability/search-list-recalled-angiotensin-ii-receptor-blockers-arbs-including-valsartan-losartan-and 2) “Another cancer-causing chemical found in widely used blood-pressure pills” https://www.cbsnews.com/news/valsartan-another-cancer-causing-chemical-found-in-widely-used-blood-pressure-medication/ 3) “Impurities in valsartan may have been present for 4 years, pose minimal risk” https://www.healio.com/news/cardiology/20190506/impurities-in-valsartan-may-have-been-present-for-4-years-pose-minimal-risk 4) “FDA…
…Blockers (ARBs) including Valsartan, Losartan and Irbesartan” https://www.fda.gov/drugs/drug-safety-and-availability/search-list-recalled-angiotensin-ii-receptor-blockers-arbs-including-valsartan-losartan-and 7) “FDA Expands Valsartan Products Recall” https://www.pharmacytimes.com/resource-centers/cardiovascular-health/fda-expands-valsartan-products-recall 8) “Valsartan, Losartan & Other BP Med Recalls 2018-19” https://www.webmd.com/hypertension-high-blood-pressure/valsartan-losatran-bp-med-recalls-2018-19 9) “NDMA, a contaminant found…
…to be prescribed for Abilify. The amount was paid as $2.3 million as federal recovery and $1.7 to Medicaid programs. Sources: http://www.otsuka-america.com/story/ https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=3428649 https://www.baumhedlundlaw.com/bristol-myers-abilify-settlement-19-billion/ https://www.mlg.law/defective-drugs/abilify-lawsuit/ https://www.empr.com/manufacture/otsuka-america-pharmaceutical-inc/ https://medtruth.com/abilify-settlement-illegal-marketing/ https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapid=182413794 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=69717 https://www.justice.gov/archive/opa/pr/2008/March/08_civ_244.html…
…the company for this drug’s side effects. The class settlement was $830 million with $232 million as fees and litigation expenses. Sources: https://www.fiercepharma.com/regulatory/merck-reaches-830m-settlement-long-running-vioxx-litigation https://www.drugwatch.com/manufacturers/merck/ https://www.reuters.com/finance/stocks/company-profile/MRK https://www.merckvioxxsecuritieslitigation.com/ https://www.washingtontimes.com/news/2014/dec/31/us-court-pays-6-million-gardasil-victims/ https://craft.co/merck-&-co https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=32271 https://www.crunchbase.com/organization/cubist-pharmaceuticals#section-overview…
…about Cleft Lip and Cleft Palate” https://www.cdc.gov/ncbddd/birthdefects/cleftlip.html 6. “Facts about Hypospadias” https://www.cdc.gov/ncbddd/birthdefects/hypospadias.html 7. “Facts about Microcephaly” https://www.cdc.gov/ncbddd/birthdefects/microcephaly.html 8. “The Safety of Stimulant Medication Use in Cardiovascular and Arrhythmia Patients” https://www.acc.org/latest-in-cardiology/articles/2015/04/28/10/06/the-safety-of-stimulant-medication-use-in-cardiovascular-and-arrhythmia-patients…
…associated with US military combat deployment” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918647/ 8) “V.A. Research on Hearing Loss” https://www.research.va.gov/pubs/docs/va_factsheets/hearingloss.pdf 9) “The Study of Attenuation Levels and the Comfort of Earplugs” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965002/ 10) “The effect of…
…https://www.valisure.com/about-us/ 13) “Formation Mechanism of NDMA from Ranitidine, Trimethylamine, and Other Tertiary Amines during Chloramination: A Computational Study” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123930/ 14) “Statement alerting patients and health care professionals of NDMA found…
…risk of cancer: Danish nationwide cohort study” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134800/#:~:text=Valsartan%20is%20an%20angiotensin%20II,treat%20hypertension%20and%20heart%20failure.&text=In%20July%202018%2C%20some%20valsartan,N%2Dnitrosodimethylamine%20(NDMA). 4) “FDA Expands Valsartan Products Recall” https://www.pharmacytimes.com/resource-centers/cardiovascular-health/fda-expands-valsartan-products-recall 5) “Valsartan, Losartan & Other BP Med Recalls 2018-19” https://www.webmd.com/hypertension-high-blood-pressure/valsartan-losatran-bp-med-recalls-2018-19 6) “NDMA, a contaminant found…
The Offices of DrugLawJournal.com are located at:
1800 North Orange Avenue, Suite C
Orlando, Florida 32804
DrugLawJournal.com is sponsored by the DDP Injury Law Group, and therefore may be considered attorney advertising. The information contained on DrugLawJournal.com is provided for informational purposes only, and should not be construed as legal or medical advice on any subject matter. No viewers of this site should discontinue taking a prescribed medication on the basis of any information on this site and should always first consult with a doctor concerning any medication. Viewers should understand that if they refrain from taking prescribed medication without appropriate medical advice they can suffer injury or death.
No viewers of content from this site, clients or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in the viewer’s state. Viewing information from DrugLawJournal.com does not create an attorney-client relationship between you and DDP Injury Law Group or DrugLawJournal.com nor is it intended to do so.The content of DrugLawJournal.com may not reflect current legal developments, verdicts or settlements. Prior results do not predict a similar outcome. For more information, please visit our web site’s disclaimer.
©2024 DrugLawJournal.com | Privacy Policy | Terms & ConditionsSign up to receive peroidic updates from our expert team of researchers, highlighting defective drugs, devices, and legal issues related to your health.
